Inventor · disambiguated record
Michael Rosen
Also filed as: ROSEN MICHAEL · ROSEN MICHAEL J · ROSEN MICHAEL JEREMY
5 granted patents·7 pending applications·20 citations·filing 2017–2024
75Inventor score
Top patents by PatentIndex Score
12 records- 0193US9976181B2Synthetic nucleic acid spike-insKARIUS INC·Filed 2017·Granted May 22, 2018·15 cites·30 claims
- 0286US11692224B2Synthetic nucleic acid spike-insKARIUS INC·Filed 2021·Granted Jul 4, 2023·1 cites·49 claims
- 0386US11078532B2Synthetic nucleic acid spike-insKARIUS INC·Filed 2018·Granted Aug 3, 2021·3 cites·40 claims
- 0485US2025034639A1Synthetic nucleic acid spike-insKARIUS INC·Filed 2024·Application pending·0 cites
- 0577US2024309427A1Reduction of signal from contaminant nucleic acidsKARIUS INC·Filed 2024·Application pending·0 cites
- 0676US12320036B2Direct-to-library methods, systems, and compositionsKARIUS INC·Filed 2021·Granted Jun 3, 2025·1 cites·20 claims
- 0765US2024344111A1Sample series to differentiate target nucleic acids from contaminant nucleic acidsKARIUS INC·Filed 2023·Application pending·0 cites
- 0857US2019256891A1Reduction of signal from contaminant nucleic acidsKARIUS INC·Filed 2019·Application pending·0 cites
- 0956US11674167B2Sample series to differentiate target nucleic acids from contaminant nucleic acidsKARIUS INC·Filed 2020·Granted Jun 13, 2023·0 cites·36 claims
- 1049US2023304102A1Biomarkers for predicting responsiveness to shp2 inhibitor therapyD2G ONCOLOGY INC·Filed 2023·Application pending·0 cites
- 1148US2023383360A1Biomarkers for predicting responsiveness to mek inhibitor monotherapy and combination therapyD2G ONCOLOGY INC·Filed 2022·Application pending·0 cites
- 1247US2021403986A1Detection and prediction of infectious diseaseKARIUS INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael Rosen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →